![Christian Itin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christian Itin
Vorstandsvorsitzender bei
AUTOLUS THERAPEUTICS PLC
Vermögen: 2 Mio $ am 31.05.2026
Profil
Christian Martin Itin is the founder of Zyomyx, Inc. (1998).
Dr. Itin is currently the Chief Executive Officer of Autolus Ltd. (2021), Chief Executive Officer & Director of Autolus Therapeutics Plc (2021), Director of Innate Pharma SA (2025), Director of Kymab Group Ltd. (2016), and Director of Autolus Holdings (UK) Ltd. (2018).
Former positions include Chairman, CEO & Head-Media Relations at Cytos Biotechnology AG (2012-2016), Chief Executive Officer at Micromet AG (2006), President, Chief Executive Officer & Director at Amgen Rockville, Inc. (2011-2012), Non-Executive Director at Kymab Ltd. (2012-2021), Non-Executive Director at Zyngenia, Inc. (2013-2014), and Director at Kuros Biosciences Ltd. (2018-2019).
Education includes a doctorate from the University of Basel.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.03.2026 | 1 166 009 ( 0,7 % ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Christian Itin
| Unternehmen | Position | Beginn |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Vorstandsvorsitzender | 01.03.2016 |
| INNATE PHARMA | Direktor/Vorstandsmitglied | 22.05.2025 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Vorstandsvorsitzender | 01.03.2016 |
Kymab Group Ltd.
 Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Direktor/Vorstandsmitglied | 23.11.2016 |
Autolus Holdings (UK) Ltd.
 Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Operates as holding company whose subsidiaries engages in pharmaceutical research and development activities | Direktor/Vorstandsmitglied | 15.06.2018 |
Ehemalige bekannte Positionen von Christian Itin
| Unternehmen | Position | Ende |
|---|---|---|
Kymab Ltd.
 Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Direktor/Vorstandsmitglied | 01.01.2021 |
| KUROS BIOSCIENCES AG | Vorsitzender | 01.06.2018 |
Cytos Biotechnology AG
 Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Vorstandsvorsitzender | 01.01.2016 |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Vorstandsvorsitzender | 02.03.2012 |
| ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Christian Itin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
65
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Zyngenia, Inc.
 Zyngenia, Inc. Drugstore ChainsRetail Trade Develops new class of biotherapeutics | Retail Trade |
Cytos Biotechnology AG
Cytos Biotechnology AG Miscellaneous Commercial ServicesCommercial Services Discovers and develops new protein drugs and innovative therapeutic concepts | Commercial Services |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs | Health Technology |
Zyomyx, Inc.
 Zyomyx, Inc. Medical SpecialtiesHealth Technology Designs and manufactures point-of-care diagnostic devices | Health Technology |
Innate Pharma SA
 Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes | Health Technology |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Develops therapeutics for cancer | Health Technology |
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops human monoclonal antibody drugs | Health Technology |
Kuros Biosciences Ltd.
 Kuros Biosciences Ltd. BiotechnologyHealth Technology Develops biological products for tissue repair | Health Technology |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Provides biopharmaceutical services | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops human monoclonal antibody drugs | Health Technology |
Autolus Holdings (UK) Ltd.
Autolus Holdings (UK) Ltd. BiotechnologyHealth Technology Operates as holding company whose subsidiaries engages in pharmaceutical research and development activities | Health Technology |
